title: Kynostatin and 17beta-estradiol prevent the apoptotic death of human neuroblastoma cells exposed to HIV-1 protease.
abstract: A significant number of adult male patients with acquired immunodeficiency syndrome develop cerebral atrophy and progressive brain disorders such as dementia complex and neuropsychiatric problems. Upon entering the brain via activated macrophages or microglias, the human immunodeficiency type 1 virus (HIV-1) may produce cytotoxic factors such as HIV-1 envelope protein (gp120) and protease. Owing to significant proteolysis of nonviral proteins, the protease derived from HIV-1 may be detrimental to brain cells and neurons. Our results revealed that HIV-1 protease, at nanomolar concentrations, was as potent as gp120 in causing neurotoxicity in human neuroblastoma neurotypic SH-SY5Y cells. As shown by the Oncor ApopTag staining procedure, HIV-1 protease significantly increased the number of apoptotic cells over the serum-free controls. Moreover, HIV-1 protease-induced neurotoxicity was blocked by a selective protease inhibitor, kynostatin (KNI-272). Antioxidants such as 17beta-estradiol, melatonin, and S-nitrosoglutathione also prevented protease-induced neurotoxicity. These findings indicate that oxidative proteolysis may mediate HIV-1 protease-induced apoptosis and the degeneration of neurons and other brain cells. Centrally active protease inhibitors and antioxidants may play an important role in preventing cerebral atrophy and associated dementia complex caused by HIV-1.
authors.affiliation: Howard Huges Medical Institute Student Teacher Internship Program, Montgomery County Public School, and National Institutes of Health, Bethesda, MD 20892-1264, USA.
authors.forename: V
authors.initials: V
authors.lastname: Hawkins
authors.forename: Q
authors.initials: Q
authors.lastname: Shen
authors.forename: C C
authors.initials: CC
authors.lastname: Chiueh
mesh_terms: D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D004958:Estradiol / Q000494:pharmacology*; D005978:Glutathione / Q000031:analogs & derivatives / Q000494:pharmacology; D016333:HIV Protease / Q000494:pharmacology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D008550:Melatonin / Q000494:pharmacology; D009447:Neuroblastoma / Q000473:pathology*; D009603:Nitroso Compounds / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D026422:S-Nitrosoglutathione; D014407:Tumor Cells, Cultured
chemical_list: D000975:Antioxidants; D017320:HIV Protease Inhibitors; D009603:Nitroso Compounds; D009842:Oligopeptides; D011994:Recombinant Proteins; D004958:Estradiol; D026422:S-Nitrosoglutathione; D016333:HIV Protease; D005978:Glutathione; D008550:Melatonin; C077822:kynostatin 272